A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma

NCT03676946 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Urothelial Carcinoma

Interventions

DRUG: ZKAB001 5mg/kg
DRUG: ZKAB001 10mg/kg
DRUG: ZKAB001 15mg/kg

Sponsor

Lee's Pharmaceutical Limited